Manufacturing compliance deadline to be extended for small drug firms
Mint Chennai|January 06, 2025
The Centre plans to extend the deadline for complying with good manufacturing practice (GMP), on par with the World Health Organization (WHO) standards for small pharmaceutical companies with a revenue of ₹250 crore or less by one year till 31 December 2025.
Priyanka Sharma

The regulation will come into force from 1 January 2026. The earlier deadline expired on 1 January 2025.

This comes against the backdrop of several representations submitted to the government by various associations requesting extension of the timeline to enable micro, small, and medium pharma companies to comply with the provisions of the revised Schedule M.

Good Manufacturing Practices (GMP) are being implemented in the country to bring quality into products by way of control on materials, methods, machines, processes, personnel, and facility or environment.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM MINT CHENNAIView all
Mint Chennai

Kick off the new year with fresh games

Despite a typical slow pace, Jan 2025 features several new game releases

time-read
1 min  |
January 08, 2025
Mint Chennai

A flagship to challenge most top smartphones in 2025

The vivo X200 Pro may emerge as the camera phone to beat in 2025. What else does the flagship have going for it?

time-read
3 mins  |
January 08, 2025
Mint Chennai

CES 2025: What Lies Ahead in Tech This Year

With more powerful computing chips, the idea of PCs compact enough to be carried around in one hand is becoming real

time-read
4 mins  |
January 08, 2025
Mint Chennai

Most favoured interpretations can prove unfavourable

India's stance on Switzerland's MFN status in a Nestle tax dispute has had adverse consequences

time-read
3 mins  |
January 08, 2025
Mint Chennai

Elon Musk and his critics are wrong about free speech on X

Both sides of this divide must read the US First Amendment again

time-read
3 mins  |
January 08, 2025
Mint Chennai

Monetary policy should lead the easing cycle our economy needs

Weak demand in the economy needs a response but budget tightening would mean the central bank must look for easing space

time-read
3 mins  |
January 08, 2025
Mint Chennai

Revision of the inflation gauge: Handle with care

India's consumer price index should be revised on the basis of the latest survey of household consumption expenditure, but with nuances of the country's situation kept well in mind

time-read
2 mins  |
January 08, 2025
Mint Chennai

May 2025 spell climate hope after a super-warm 2024

Let's harness the negativity bias that humans are predisposed to for measures aimed at faster climate action

time-read
3 mins  |
January 08, 2025
Mint Chennai

India Needs a Tad More Ambition and Resolve to Boost GDP Growth

We must focus on long-term fixes rather than near-term uncertainties for fast economic expansion

time-read
3 mins  |
January 08, 2025
Mint Chennai

Insights on When to Step Back From the Stock Market

The stock surge since 2020 has made it harder to convince investors to step back if needed

time-read
3 mins  |
January 08, 2025